Aspira Women’s Health (NASDAQ:AWH) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Aspira Women’s Health (NASDAQ:AWH) announced its quarterly earnings results on Monday. The company reported ($0.28) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.32) by $0.04, Yahoo Finance reports. The firm had revenue of $2.42 million during the quarter, compared to analysts’ expectations of $2.60 million. During the same period in the previous year, the company posted ($0.28) earnings per share.

Aspira Women’s Health Trading Up 5.5 %

Shares of NASDAQ AWH opened at $1.15 on Wednesday. The stock has a market cap of $14.32 million, a price-to-earnings ratio of -0.75 and a beta of 1.54. The stock’s 50-day moving average is $1.45 and its 200 day moving average is $2.81. Aspira Women’s Health has a 1-year low of $0.86 and a 1-year high of $6.75.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Aspira Women’s Health from a “sell” rating to a “hold” rating in a report on Wednesday.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.